sur BioVersys AG
BioVersys Sets March 26 for Full-Year 2024 Financial Results Release
On March 14, 2025, BioVersys AG, a biopharmaceutical company based in Basel, Switzerland, announced it will release its Full-Year 2024 financial results on March 26, 2025. The results will be published at 7:00 AM CET, followed by a conference call and webcast at 2:00 PM CET.
The company focuses on developing novel antibacterial products targeting multidrug-resistant bacteria. The leadership team will provide insights into BioVersys' financial performance, strategic plans, and therapeutic pipeline during the event.
Interested parties can register for the conference call to receive dial-in details. The webcast will also be available online. Attendees are advised to mute their browser audio during the session.
R. H.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de BioVersys AG